A randomised pilot Phase II study of doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC) given 2 weekly with pegfilgrastim (accelerated) vs 3 weekly (standard) for women with early breast cancer.

A randomised pilot Phase II study of doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC) given 2 weekly with pegfilgrastim (accelerated) vs 3 weekly (standard) for women with early breast cancer.

Item
http://www.wikidata.org/entity/Q37081127
Dose-dense paclitaxel versus docetaxel following FEC as adjuvant chemotherapy in axillary node-positive early breast cancer: a multicenter randomized study of the Hellenic Oncology Research Group (HORG).Dose-dense epirubicin and cyclophosphamide followed by weekly Paclitaxel in node-positive breast cancerHigh rate of extra-haematological toxicity compromises dose-dense sequential adjuvant chemotherapy for breast cancer.Molecular Pathways: Targeting Cancer Stem Cells Awakened by Chemotherapy to Abrogate Tumor Repopulation.Dose-dense epirubicin and cyclophosphamide followed by docetaxel as adjuvant chemotherapy in node-positive breast cancerPrevention of chemotherapy-induced neutropenia with pegfilgrastim: pharmacokinetics and patient outcomes.Chemotherapy regimens in early breast cancer: major controversies and future outlook.Hydralazine-valproate: a repositioned drug combination for the epigenetic therapy of cancer.Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors.Independent replication of polymorphisms predicting toxicity in breast cancer patients randomized between dose-dense and docetaxel-containing adjuvant chemotherapy.Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients.
P2860

A randomised pilot Phase II study of doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC) given 2 weekly with pegfilgrastim (accelerated) vs 3 weekly (standard) for women with early breast cancer.

Item
http://www.wikidata.org/entity/Q37081127
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A randomised pilot Phase II st ...... omen with early breast cancer.
@en
A randomised pilot Phase II study of doxorubicin and cyclophosphamide
@nl
type
label
A randomised pilot Phase II st ...... omen with early breast cancer.
@en
A randomised pilot Phase II study of doxorubicin and cyclophosphamide
@nl
prefLabel
A randomised pilot Phase II st ...... omen with early breast cancer.
@en
A randomised pilot Phase II study of doxorubicin and cyclophosphamide
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
A randomised pilot Phase II st ...... omen with early breast cancer.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932